BR0010151A - Inibidores do sistema de clivagem de glicina como antipsicóticos potenciais - Google Patents

Inibidores do sistema de clivagem de glicina como antipsicóticos potenciais

Info

Publication number
BR0010151A
BR0010151A BR0010151-6A BR0010151A BR0010151A BR 0010151 A BR0010151 A BR 0010151A BR 0010151 A BR0010151 A BR 0010151A BR 0010151 A BR0010151 A BR 0010151A
Authority
BR
Brazil
Prior art keywords
glycine cleavage
potential
cleavage system
system inhibitors
antipsychotics
Prior art date
Application number
BR0010151-6A
Other languages
English (en)
Inventor
Michael Arlt
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR0010151A publication Critical patent/BR0010151A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"INIBIDORES DO SISTEMA DE CLIVAGEM DE GLICINA COMO ANTIPSICóTICOS POTENCIAIS". A invenção refere-se ao inibidor do sistema de clivagem de glicina e a seu uso como agentes antipsicóticos potenciais. A invenção refere-se além disso a um processo para tratamento de humanos tendo psicose, psicose associada com uma doença, esquizofrenia, doença de Alzheimer ou outros distúrbios psicóticos relacionados.
BR0010151-6A 1999-04-29 2000-04-17 Inibidores do sistema de clivagem de glicina como antipsicóticos potenciais BR0010151A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13164799P 1999-04-29 1999-04-29
EP99108480 1999-04-30
PCT/EP2000/003456 WO2000066110A1 (en) 1999-04-29 2000-04-17 Glycine cleavage system inhibitors as potential antipsychotics

Publications (1)

Publication Number Publication Date
BR0010151A true BR0010151A (pt) 2002-06-11

Family

ID=56290006

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010151-6A BR0010151A (pt) 1999-04-29 2000-04-17 Inibidores do sistema de clivagem de glicina como antipsicóticos potenciais

Country Status (12)

Country Link
US (1) US6395780B1 (pt)
EP (1) EP1185259A1 (pt)
JP (1) JP2002543124A (pt)
KR (1) KR20020008167A (pt)
AU (1) AU4748100A (pt)
BR (1) BR0010151A (pt)
CA (1) CA2372073A1 (pt)
CZ (1) CZ20013786A3 (pt)
MX (1) MXPA01010933A (pt)
NO (1) NO20015247D0 (pt)
PL (1) PL353180A1 (pt)
WO (1) WO2000066110A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846913B2 (en) * 2003-12-29 2010-12-07 Mcdevitt Jason Patrick Compositions and methods to treat recurrent medical conditions
JP4757024B2 (ja) * 2002-11-07 2011-08-24 テクニオン リサーチ アンド ディベラップメント ファウンデイション リミテッド 神経保護鉄キレート剤及びそれを含む医薬組成物
GB2398497A (en) * 2003-02-19 2004-08-25 Walcom Animal Science Composition for improving immunity of animals
US20070037882A1 (en) * 2003-04-22 2007-02-15 Astellas Pharma Inc. Remedy for cerebral neurodegenerative diseases using ppar agonist
JP5707014B2 (ja) * 2003-10-15 2015-04-22 プロビオドルグ エージー グルタミニル、及びグルタミン酸シクラーゼのエフェクターの使用
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
EP2433626B1 (en) 2003-11-25 2015-11-04 Technion Research & Development Foundation Ltd. Compositions and methods for treatment of cardiovascular disorders and diseases
WO2005067899A2 (en) * 2004-01-13 2005-07-28 Omega Bio-Pharma (I.P.2) Limited Methods for treating stress and affecting biological immune systems using a cysteamine compound
JP2005232148A (ja) * 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用
JP4991037B2 (ja) 2004-04-01 2012-08-01 カーディオム ファーマ コーポレイション イオンチャネル調節化合物を含む薬物結合体
ITMI20040876A1 (it) * 2004-04-30 2004-07-30 Univ Degli Studi Milano Inibitori delle istone deacetilasi-hdac-quali agenti ipolipidemizzati per la terapia e la prevenzione dell'arteriosclerosi e malattie cardiovascolari
AU2006251832A1 (en) * 2005-05-27 2006-11-30 Queen's University At Kingston Treatment of protein folding disorders
FR2890563B1 (fr) * 2005-09-09 2007-10-19 Servier Lab Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent
US8263655B2 (en) * 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
KR200453511Y1 (ko) * 2009-12-29 2011-05-13 한국강성(주) 마이크로 유에스비 커넥터 플러그
NZ602111A (en) 2010-02-03 2014-10-31 Pharma Two B Ltd Extended release formulations of rasagiline and uses thereof
NZ630026A (en) * 2012-02-10 2016-06-24 Whitehead Biomedical Inst Inhibition of the glycine cleavage system for treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218709D0 (en) * 1992-09-04 1992-10-21 Salim Aws S M Biologically active health formulation
WO1999049860A1 (en) * 1998-03-30 1999-10-07 The Endowment For Research In Human Biology, Inc. Agents and methods for modulation of zinc transfer by metallothionein

Also Published As

Publication number Publication date
MXPA01010933A (es) 2002-06-21
WO2000066110A1 (en) 2000-11-09
CZ20013786A3 (cs) 2002-02-13
NO20015247L (no) 2001-10-26
NO20015247D0 (no) 2001-10-26
PL353180A1 (en) 2003-11-03
KR20020008167A (ko) 2002-01-29
EP1185259A1 (en) 2002-03-13
US6395780B1 (en) 2002-05-28
CA2372073A1 (en) 2000-11-09
AU4748100A (en) 2000-11-17
JP2002543124A (ja) 2002-12-17

Similar Documents

Publication Publication Date Title
BR0010151A (pt) Inibidores do sistema de clivagem de glicina como antipsicóticos potenciais
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
PT1005453E (pt) Compostos de benzeno substituido como agentes de reducao antiproliferativa
EA200200262A1 (ru) Пиперазиновые производные и их применение в качестве противовоспалительных агентов
MA26901A1 (fr) Nouvelle composition pharmaceutique
PT1115701E (pt) Ureias de arilsulfonanilida
EA199900324A1 (ru) Комбинированная терапия для лечения психозов
ATE249214T1 (de) Pentafluorobenzensulfonamide und analoge
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
ATE225351T1 (de) Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel
PT1049703E (pt) Aldeido do acido n-¬2-(5-benziloxicarbonilamino-6-oxo-2-(4-fluorofenil)-1,6-di-hidro-1-pirimidinil)acetoxil|-l-aspartico como inibidor da enzima de conversao da interleucina-1beta in vivo
UY26677A1 (es) Heterociclos que son inhibidores de la enzima impdh
BR0206495A (pt) Tratamento de distúrbios de cns empregando antagonistas de oxidase de d-aminoácido e oxidase de d-aspartato
ES2138983T3 (es) Uso de derivados del acido 2-(n-(2-aminoetil)amino)-acetico para el tratamiento de enfermedades condicionadas por glicosilacion no enzimatica.
ES2178205T3 (es) Compuestos amida indazol como agentes serotoninergicos.
DOP2000000106A (es) 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-o-tolil-piridin-3-il)-isobutiramida
ES2084996T3 (es) Piperazinas sustituidas utiles como agentes para el sistema nervioso central.
BR0114697A (pt) Derivados em ponte de piperazina
BR9712081A (pt) Novos derivados de pept¡deos tendo res¡duo tiazolil-alanina
BR9814042A (pt) &#34;compostos de tiofeno condensados e seu uso farmacêutico&#34;
BR9801132A (pt) N-heterociclos fundidos, substituìdos com benzilóxi, processo para a sua preparação e seu uso como antagonistas de receptor de bradiquinina.
BR0012327A (pt) Pirrolidinas e piperidinas neurotróficas, e composições e métodos relacionados
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
ES2184300T3 (es) Derivados de aminoacidos utiles para tratar el accidente vascular encefalico.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]